No Data
No Data
Alterity Therapeutics Price Target Announced at $8.00/Share by Maxim Group
Alterity Therapeutics Analyst Ratings
Maxim Group Initiates Alterity Therapeutics(ATHE.US) With Buy Rating, Announces Target Price $8
Alterity Therapeutics' Vision for Neurodegenerative Care | NYSE:ATHE, ASX:ATH
Alterity Therapeutics Announced That The Last Patient In The ATH434-201 Phase 2 Trial, A Randomized, Double-blind, Placebo-controlled Investigation In Early-stage Multiple System Atrophy, Has Completed The Study And Topline Results Are Expected To Be...
12 Health Care Stocks Moving In Friday's Pre-Market Session
Unlock the Full List